Abstract
Intramuscular injection of haloperidol or epinephrine in a minimum effective dose produces the maximum antipsychotic effect in rat model of schizophrenia, i.e. completely removes stereotypy, hyperlocomotion, and ataxia induced by MK-801. Haloperidol in the specified dose induces catalepsy, while epinephrine exhibits no cataleptogenic effect. Combined intramuscular injection of haloperidol and epinephrine in the threshold doses, ineffective in monotherapy, causes the maximum antipsychotic effect, but not catalepsy. Preliminary anesthesia of the gastric mucosa with 1% lidocaine and blockade of intramural ganglia in the gastric mucosa with hexamethonium completely abolished the potentiated antipsychotic effects produced by combined treatment with haloperidol and epinephrine. Hence, potentiation of the antipsychotic effect of haloperidol with epinephrine is related to stimulation of afferents in the gastric mucosa.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
S. E. Serdyuk and V. E. Gmiro, Ros. Fiziol. Zh., 83, No. 8, 111–120 (1997).
S. E. Serdyuk and V. E. Gmiro, Ibid., 81, No. 9, 40–51 (1995).
J. Ananth, S. Parameswaran, and B. Hara, Curr. Pharm. Res., 10, No. 18, 2205–2217 (2004).
M. Bourin, M. Malinge, E. Vasar, and J. Bradwejn, Fundam. Clin. Pharmacol., 10, No. 2, 116–126 (1996).
A. Campbell, R. J. Baldessarini, and M. C. Cremens, Neuropharmacology, 27, No. 11, 1197–1199 (1988).
T. Hamamura, Y. Kazahaya, and S. Otsuki, Brain Res., 483, No. 1, 78–83 (1989).
M. Hashimoto, T. Hirai, K. Oguchi, and H. G. Yasuhara, Jpn. J. Pharmacol., 41, No. 1, 127–130 (1986).
D. C. Hoffman, J. Neural Transm. Gen. Sect., 89, Nos. 1–2, 1–10 (1992).
S. E. Krahl, S. S. Senanayke, and A. Handforth, Epilepsy Res., 38, Nos. 2–3, 171–175 (2000).
K. Matsubara and A. Matsushita, Jpn. J. Pharmacol., 38, No. 4, 381–390 (1985).
A. R. Mohn, R. R. Gainetdinov, M. G. Caron, and B. H. Koller, Cell, 98, No. 4, 427–436 (1999).
N. P. Nair, S. Lal, and D. M. Bloom, Prog. Neuropsychopharmacol. ]Biol. Psychiatry, 9, No. 5–6, 515–524 (1985).
M. Tada, K. Shirakawa, N. Matsuoka, and S. Mutoh, Psychopharmacology (Berl.), 176, No. 1, 94–100 (2004).
A. B. Tort, O. P. Dall’Igna, R. V. de Oliveira, et al., Ibid., 177, No. 3, 344–348 (2005).
Y. C. Yen, F. W. Lung, and M. Y. Chong, Prog. Neuropsychopharmacol. Biol. Psychiatry, 28, No. 2, 285–290 (2004).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 143, No. 5, pp. 554–556, May, 2007
Rights and permissions
About this article
Cite this article
Gmiro, V.E., Serdyuk, S.E. Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats. Bull Exp Biol Med 143, 617–619 (2007). https://doi.org/10.1007/s10517-007-0197-5
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-007-0197-5